Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LMBR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LIMS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PIWIL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
WDR3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HCG11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CLEC4C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
JAK3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01020 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AHSG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRAP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MBLAC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDC42 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SDCBP2-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01210 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ST3GAL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C12orf65 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on